Related Experiment Video

Updated: May 22, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

MicroRNAs as putative mediators of treatment response in prostate cancer

Fardod O'Kelly1, Laure Marignol, Armelle Meunier

  • 1Prostate Molecular Oncology Research Group, Academic Unit of Clinical and Molecular Oncology, Institute of Molecular Medicine, St James' Hospital & Trinity College, University of Dublin, James's Street, Dublin 8, Ireland.

Nature Reviews. Urology
|May 23, 2012
PubMed

Insights

MicroRNAs (miRNAs) regulate gene expression and may influence prostate cancer treatment outcomes. Further research into their role in radiotherapy, chemotherapy, and androgen suppression response is crucial for developing new therapies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of post-transcriptional gene expression.
  • miRNAs are implicated in prostate cancer initiation and progression.
  • Emerging evidence suggests miRNAs influence response to various prostate cancer treatments.

Purpose of the Study:

  • To investigate the role of miRNAs in treatment response in prostate cancer.
  • To explore the mechanisms by which miRNAs affect response to radiotherapy, chemotherapy, and androgen suppression.
  • To identify novel therapeutic targets based on miRNA function in treatment response.

Main Methods:

  • Literature review and analysis of existing studies on miRNAs and prostate cancer treatment response.
  • Exploration of potential molecular mechanisms of miRNA-mediated regulation.
  • Identification of knowledge gaps in current research.

Main Results:

  • The functional role of miRNAs in prostate cancer treatment response is currently under-investigated.
  • The mechanisms underlying miRNA involvement in treatment response are multifactorial and poorly understood.
  • A limited number of studies have focused on the functional impact of miRNAs on treatment outcomes.

Conclusions:

  • Understanding miRNA roles in response to radiotherapy, chemotherapy, and androgen suppression is critical.
  • Elucidating these roles can open new avenues for developing innovative prostate cancer therapies.
  • Further functional studies are needed to fully leverage miRNAs for improved treatment strategies.

More Related Videos

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...